Equities
  • Price (USD)29.90
  • Today's Change-0.585 / -1.92%
  • Shares traded50.82k
  • 1 Year change+26.25%
  • Beta--
Data delayed at least 15 minutes, as of Feb 17 2026 15:59 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
4519:TYO since
announced
Transaction
value
Renalys Pharma IncDeal completed24 Oct 202524 Oct 2025Deal completed28.18%203.17m
Data delayed at least 15 minutes, as of Feb 17 2026 06:30 GMT.

Institutional shareholders

0.07%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price Associates, Inc. (IM)as of 31 Jan 20261.24m0.04%
Strategic Advisers LLCas of 31 Dec 2025959.20k0.03%
Confluence Investment Management LLCas of 31 Dec 202545.37k0.00%
RhumbLine Advisers LPas of 31 Dec 202544.38k0.00%
Sterling Capital Management LLCas of 31 Dec 202544.02k0.00%
Causeway Capital Management LLCas of 05 Feb 202634.81k0.00%
GAMMA Investing LLCas of 31 Dec 202512.65k0.00%
PNC Wealth Management LLCas of 31 Dec 202510.55k0.00%
BlackRock Advisors LLCas of 05 Feb 20268.45k0.00%
ShariaPortfolio, Inc.as of 05 Feb 20268.12k0.00%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.